Contrive Datum Insights has published "Durable Medical Equipment Market Size, Share & Industry Analysis, By Product (Wheelchairs, Scooters, Walker And Rollators, Cranes And Crutches, Door Openers, Other Devices, Commodes And Toilets, Mattress & Bedding Devices, Monitoring And Therapeutic Devices, Blood Glucose Monitors, Continuous Passive Motion (CPM), Infusion Pumps Market, Nebulizers, Oxygen Equipment, Suction Pumps, Traction Equipment, Others Equipment), End-use (Hospitals, Home Healthcare, Nursing Homes, Other End-user), Distribution channel (Retail Pharmacies & Medical Stores, Online Retail / E-commerce, Hospital & Institutional Pharmacies, Home Care / Rental Providers), Payment/reimbursement type (Insurance-Reimbursed, Government Program-Funded, Out-of-Pocket/Private Pay), Age group (Geriatric, Adult, Pediatric), and Regional Forecast, 2026-2034". The study sizes the global durable medical equipment market at USD 235 billion in 2025 and projects growth from USD 248.5 billion in 2026 to USD 400 billion by 2034, a compound annual growth rate of 6.12% across the forecast period.
Durable medical equipment covers devices intended for repeated, extended use by patients recovering from injury, managing chronic conditions, or requiring daily functional support, spanning mobility aids, patient handling and hygiene equipment, respiratory and monitoring devices, and infusion and therapeutic systems. These products are built to withstand sustained use in hospitals, nursing facilities, and private homes rather than single-use clinical settings. Buyers range from hospitals and long-term care operators purchasing at scale to individual patients and caregivers acquiring equipment directly or through insurance-linked rental and purchase programs.
Aging population and rising chronic-disease prevalence expanding home-based care demand
Aging population and rising chronic-disease prevalence expanding home-based care demand is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.12% a year, the product lines exposed to it move fastest: Monitoring And Therapeutic Devices compounds at 8.52%, taking its share of revenue from 8% to 9.8% and its value from USD 18.8 billion to USD 39.2 billion.
On the upside, the study's bull case assumes reimbursement and rental-program coverage expands faster than the base case across the largest payer markets, and connected monitoring categories reach clinical adoption sooner than assumed, which would take 2034 revenue to USD 414.4 billion against the USD 400 billion base case.
The downside is specific. Reimbursement policy tightens or coverage expansion stalls in the largest payer markets, and component or logistics costs push category prices above the levels assumed in the base case, and 2034 revenue lands at USD 382 billion. Wheelchairs is the drag, 14% of the 2025 base compounding at 4.8% while the market runs at 6.12%.
Where the Competition Actually Sits
Two positions matter, and they are set by product. Wheelchairs carries 14% of 2025 revenue (USD 32.9 billion) and is still the largest line in 2034 at 12.5%, hard to take from an incumbent. Monitoring And Therapeutic Devices, at 8.52%, is where the USD 235 billion base is redistributed. The two demand different capabilities.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Product | Wheelchairs | 14% · USD 32.9 billion | — |
| End-use | Home Healthcare | 38% · USD 89.3 billion | — |
| Distribution channel | Retail Pharmacies & Medical Stores | 34% · USD 79.9 billion | Online Retail / E-commerce 11.97% |
| Payment/reimbursement type | Insurance-Reimbursed | 46% · USD 108.1 billion | Government Program-Funded 7.22% |
| Age group | Geriatric | 58% · USD 136.3 billion | Pediatric 7.49% |
- North America was the largest region in 2025, holding 38% of global revenue at USD 89.3 billion and reaching USD 138 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24.5% in 2025 to 29% in 2034, with revenue growing from USD 57.58 billion to USD 116 billion.
- Middle East and Africa stays the smallest contributor across the period: 5% of revenue in 2025 and 5.2% in 2034.
- The fastest product line is Monitoring And Therapeutic Devices, forecast to compound at 8.52% through the period.
- The United States is the largest single country market at USD 75.91 billion in 2025, 32.3% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by product, and by end-use, distribution channel, payment/reimbursement type and age group. The headline total carries bear, base and bull cases at USD 382 billion and USD 414.4 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.